T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGR
1676
DELISTED
Avangrid, Inc.
AGR
| $1.54M | ﹤0.01% |
30,491
+2,010
| +7% | +$102K |
|
1677
Crane NXT
CXT
$2.96B
| $1.53M | ﹤0.01% |
52,717
-547
| -1% | -$15.9K |
|
1678
Mercury Systems
MRCY
$6.59B
| $1.53M | ﹤0.01% |
21,706
+241
| +1% | +$16.7K |
|
1679
Coherus Oncology
CHRS
$176M
| $1.5M | ﹤0.01% |
68,115
-426,104
| -86% | -$7.4M |
|
1680
MSC Industrial Direct
MSM
$6.77B
| $1.5M | ﹤0.01% |
20,139
+112
| +0.6% | +$8.64K |
|
1681
Transocean
RIG
$6.39B
| $1.49M | ﹤0.01% |
232,038
+1,733
| +0.8% | +$12.9K |
|
1682
Integra LifeSciences
IART
$1.42B
| $1.49M | ﹤0.01% |
26,601
+24
| +0.1% | +$1.24K |
|
|
REGI
1683
DELISTED
Renewable Energy Group, Inc.
REGI
| $1.49M | ﹤0.01% |
93,636
+6,800
| +8% | +$125K |
|
1684
CareTrust REIT
CTRE
$9.18B
| $1.48M | ﹤0.01% |
62,351
+6,777
| +12% | +$164K |
|
1685
Terex
TEX
$7.57B
| $1.48M | ﹤0.01% |
47,146
+323
| +0.7% | +$9.91K |
|
1686
Four Corners Property Trust
FCPT
$2.76B
| $1.47M | ﹤0.01% |
53,869
+160
| +0.3% | +$4.58K |
|
|
QEP
1687
DELISTED
QEP RESOURCES, INC.
QEP
| $1.46M | ﹤0.01% |
202,243
+27,024
| +15% | +$197K |
|
|
PRO
1688
DELISTED
PROS Holdings
PRO
| $1.46M | ﹤0.01% |
23,016
+106
| +0.5% | +$5.58K |
|
1689
Axos Financial
AX
$5.72B
| $1.46M | ﹤0.01% |
53,388
+139
| +0.3% | +$4.09K |
|
1690
Kforce
KFRC
$1.08B
| $1.45M | ﹤0.01% |
41,319
-2,949
| -7% | -$106K |
|
|
IRBT
1691
DELISTED
iRobot
IRBT
| $1.45M | ﹤0.01% |
15,809
+1,970
| +14% | +$200K |
|
1692
Fox Factory Holding Corp
FOXF
$886M
| $1.45M | ﹤0.01% |
17,508
+120
| +0.7% | +$8.9K |
|
|
KEM
1693
DELISTED
KEMET Corporation
KEM
| $1.44M | ﹤0.01% |
76,678
+3,535
| +5% | +$61.9K |
|
1694
AMC Global Media
AMCX
$496M
| $1.44M | ﹤0.01% |
26,436
-2,598
| -9% | -$146K |
|
1695
Granite Construction
GVA
$5.41B
| $1.44M | ﹤0.01% |
29,813
+165
| +0.6% | +$7.21K |
|
1696
UMB Financial
UMBF
$11.5B
| $1.42M | ﹤0.01% |
21,635
+2,883
| +15% | +$190K |
|
1697
Liberty Latin America Class A
LILA
$1.67B
| $1.42M | ﹤0.01% |
128,503
-34,556
| -21% | -$423K |
|
1698
Outfront Media
OUT
$5.24B
| $1.42M | ﹤0.01% |
55,750
+50
| +0.1% | +$1.22K |
|
1699
TriNet
TNET
$3.22B
| $1.41M | ﹤0.01% |
20,837
+128
| +0.6% | +$8.14K |
|
1700
Patterson-UTI
PTEN
$4.16B
| $1.41M | ﹤0.01% |
122,567
+16,936
| +16% | +$218K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.